{"id":16242,"date":"2022-05-24T18:25:53","date_gmt":"2022-05-24T16:25:53","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=16242"},"modified":"2022-05-24T18:25:53","modified_gmt":"2022-05-24T16:25:53","slug":"poteligeo-mogamulizumab-medicament-orphelin-inscrit-sur-la-liste-en-sus-au-journal-officiel","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/poteligeo-mogamulizumab-medicament-orphelin-inscrit-sur-la-liste-en-sus-au-journal-officiel\/","title":{"rendered":"POTELIGEO\u00ae (mogamulizumab), m\u00e9dicament orphelin,  inscrit sur la liste en sus au Journal Officiel"},"content":{"rendered":"<p><strong>Le laboratoire Kyowa Kirin Pharma annonce l\u2019inscription sur la liste en sus de POTELIGEO<sup>\u00ae<\/sup>, premi\u00e8re th\u00e9rapie cibl\u00e9e* indiqu\u00e9e dans le traitement des patients adultes ayant un mycosis fongo\u00efde (MF) ou un syndrome de S\u00e9zary (SS)<\/strong>,<strong> apr\u00e8s \u00e9chec d\u2019au moins un traitement syst\u00e9mique, publi\u00e9e au Journal Officiel le 17 mars 2022.<\/strong><\/p>\n<p>Au sein des \u00e9tablissements de sant\u00e9, la liste en sus est un dispositif de financement d\u00e9rogatoire qui permet la prise en charge par l\u2019Assurance Maladie de sp\u00e9cialit\u00e9s pharmaceutiques hospitali\u00e8res innovantes telles que Poteligeo<sup>\u00ae<\/sup>, en sus des tarifs d\u2019hospitalisation, sous certaines conditions d\u2019\u00e9ligibilit\u00e9.<\/p>\n<p>Depuis le 3 mars 2021, Poteligeo<sup>\u00ae<\/sup> est inscrit sur la liste des sp\u00e9cialit\u00e9s pharmaceutiques agr\u00e9\u00e9es \u00e0 l\u2019usage des collectivit\u00e9s et divers services publics. A cette date, toutes les conditions n\u2019\u00e9taient pas remplies pour permettre une inscription de Poteligeo<sup>\u00ae<\/sup> sur la liste en sus, notamment le niveau d\u2019ASMR IV obtenu par Poteligeo<sup>\u00ae <\/sup>lors de son passage en Commission de la Transparence (un niveau d\u2019ASMR III au minimum \u00e9tant alors requis, sauf conditions sp\u00e9ciales).<\/p>\n<p style=\"text-align: right;\"><em>D&#8217;apr\u00e8s un communiqu\u00e9 de presse de Kyowa Kirin Pharma.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Le laboratoire Kyowa Kirin Pharma annonce l\u2019inscription sur la liste en sus de POTELIGEO\u00ae, premi\u00e8re th\u00e9rapie cibl\u00e9e* indiqu\u00e9e dans le traitement des patients adultes ayant un mycosis fongo\u00efde (MF) ou [&hellip;]<\/p>","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[21],"tags":[],"ppma_author":[457],"class_list":["post-16242","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","author-pascale-raoul"],"aioseo_notices":[],"authors":[{"term_id":457,"user_id":17,"is_guest":0,"slug":"pascale-raoul","display_name":"Pascale Raoul","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/16242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=16242"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/16242\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=16242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=16242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=16242"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=16242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}